Life Sciences, Journal Year: 2024, Volume and Issue: 339, P. 122420 - 122420
Published: Jan. 11, 2024
Language: Английский
Life Sciences, Journal Year: 2024, Volume and Issue: 339, P. 122420 - 122420
Published: Jan. 11, 2024
Language: Английский
International Journal of Molecular Sciences, Journal Year: 2023, Volume and Issue: 24(21), P. 15644 - 15644
Published: Oct. 27, 2023
The gut microbiome is intimately intertwined with the host immune system, having effects on systemic system. Dysbiosis of has been linked not only to gastrointestinal disorders but also conditions skin, lungs, and brain. Commensal bacteria can affect status through a stimulation innate training adaptive competitive exclusion pathogens. improve response production immunomodulating compounds such as microbe-associated molecular patterns (MAMPs), short-chain fatty acids (SCFAs), secondary bile acids. microbiome, especially when in dysbiosis, plastic be manipulated introduction beneficial or adjustment nutrients stimulate expansion taxa. complex nature tract (GIT) ecosystem complicates use these methods, similar treatments have various results individuals different residential microbiomes differential health statuses. A more complete understanding interaction between commensal species, genetics, system needed for effective interventions developed implemented clinical setting.
Language: Английский
Citations
9Food & Function, Journal Year: 2023, Volume and Issue: 15(1), P. 236 - 254
Published: Nov. 29, 2023
Bifidobacterium animalis subsp. lactis pretreatment coordinately regulates colonic and serum metabolites, influencing the systemic immune responses of neonatal rats to Salmonella infection.
Language: Английский
Citations
9European Journal of Pediatrics, Journal Year: 2024, Volume and Issue: unknown
Published: Oct. 3, 2024
Language: Английский
Citations
3Microbiome Research Reports, Journal Year: 2023, Volume and Issue: 3(1)
Published: Oct. 31, 2023
Gut microbiota research has gained a tremendous amount of attention from the scientific community because its contribution to gut homeostasis, human health, and various pathophysiological conditions. The early colonizer gut, i.e., bifidobacterial, emerged as an efficient probiotic in diseased conditions, including cancer. This review explores pros cons Bifidobacterium malignancies therapeutic strategies. We have illustrated controversial role bifidobacteria participating well described current knowledge regarding use anticancer therapies. Ultimately, this article also addresses need for further extensive elucidating mechanism how is involved indirectly affecting tumor microenvironment. Exhaustive large-scale required solve questions involvement cancer research.
Language: Английский
Citations
8Life Sciences, Journal Year: 2024, Volume and Issue: 339, P. 122420 - 122420
Published: Jan. 11, 2024
Language: Английский
Citations
2